Article
Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin.
Archives of virology - 1 Sept 2016
Abdelraheem Wedad M, Hassuna Noha A, Abuloyoun Sahar M, Abdel Ghany Hend M, Rizk Hazem A, Abdelwahab Sayed F
Abstract excerpt
A single-nucleotide polymorphism (SNP) in the interleukin (IL)-28B gene was used as a major predictor of the response to treatment in patients with hepatitis C virus (HCV) infection. Data examining the role of IL-10 and IL-18 gene polymorphisms among HCV genotype 4 (G4)-infected Egyptians in response to pegylated interferon (PEG-IFN) plus ribavirin (RBV) therapy are limited. This study investigated the impact of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.